<SEC-DOCUMENT>0001209191-19-015055-index.html : 20190301
<SEC-HEADER>0001209191-19-015055.hdr.sgml : 20190301
<ACCEPTANCE-DATETIME>20190301165553
ACCESSION NUMBER:		0001209191-19-015055
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190227
FILED AS OF DATE:		20190301
DATE AS OF CHANGE:		20190301

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Loewy Caroline M
		CENTRAL INDEX KEY:			0001367451

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38697
		FILM NUMBER:		19650300

	MAIL ADDRESS:	
		STREET 1:		300 ELLIOTT AVE WEST
		STREET 2:		SUITE 500
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98119-4114

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PhaseBio Pharmaceuticals Inc
		CENTRAL INDEX KEY:			0001169245
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				030375697
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1 GREAT VALLEY PARKWAY
		STREET 2:		SUITE 30
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		(610) 981-6500

	MAIL ADDRESS:	
		STREET 1:		1 GREAT VALLEY PARKWAY
		STREET 2:		SUITE 30
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Phase Biosciences Inc
		DATE OF NAME CHANGE:	20061013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DT BIOSCIENCES INC
		DATE OF NAME CHANGE:	20020315
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>